Chemoinformaics analysis of TRISFLAVASPIDIC-ACID
Molecular Weight | 654.709 | nRot | 13 |
Heavy Atom Molecular Weight | 612.373 | nRig | 24 |
Exact Molecular Weight | 654.268 | nRing | 3 |
Solubility: LogS | -2.2 | nHRing | 0 |
Solubility: LogP | 5.434 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 89 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 47 | No. of Aromatic Carbocycles | 2 |
nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 35 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 12 | No. of Arom Bond | 12 |
nHA | 12 | APOL | 96.0793 |
nHD | 8 | BPOL | 45.6067 |
QED | 0.128 |
Synth | 4.525 |
Natural Product Likeliness | 1.398 |
NR-PPAR-gamma | 0.046 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.833 |
Pgp-sub | 0.999 |
HIA | 0.21 |
CACO-2 | -6.037 |
MDCK | 0.0000102 |
BBB | 0.001 |
PPB | 0.964989 |
VDSS | 0.508 |
FU | 0.0109604 |
CYP1A2-inh | 0.028 |
CYP1A2-sub | 0.873 |
CYP2c19-inh | 0.034 |
CYP2c19-sub | 0.077 |
CYP2c9-inh | 0.451 |
CYP2c9-sub | 0.959 |
CYP2d6-inh | 0.138 |
CYP2d6-sub | 0.154 |
CYP3a4-inh | 0.162 |
CYP3a4-sub | 0.222 |
CL | 9.874 |
T12 | 0.154 |
hERG | 0.039 |
Ames | 0.034 |
ROA | 0.235 |
SkinSen | 0.797 |
Carcinogencity | 0.125 |
EI | 0.873 |
Respiratory | 0.036 |
NR-Aromatase | 0.306 |
Antiviral | Yes |
Prediction | 0.955097 |